Maryam Jangani
About Maryam Jangani
Maryam Jangani is a Senior Scientist at Adaptimmune, where she has worked since 2021. She specializes in the study of immune cell interactions within the tumor microenvironment and has extensive experience in molecular, immunological, and genomic screening studies.
Work at Adaptimmune
Maryam Jangani has been serving as a Senior Scientist at Adaptimmune since 2021. In this role, she focuses on advancing research related to immune cell functions and their interactions within the tumor microenvironment. Her work contributes to the development of innovative therapies aimed at improving patient outcomes in cancer treatment.
Previous Experience in Research
Prior to her position at Adaptimmune, Maryam Jangani worked as a Principal Researcher at Eisai EMEA for 10 months in 2020 to 2021. She has also held the role of Senior Scientist at Horizon Discovery for 6 months in 2019 to 2020 in Cambridge, United Kingdom. Additionally, she served as a Postdoctoral Research Associate at Barts Cancer Institute from 2012 to 2016, where she engaged in significant cancer research.
Education and Expertise
Maryam Jangani earned her Master of Research (MRes) in Biological and Biomedical Sciences from the University of Liverpool in 2008. She also holds a Bachelor of Science (BSc) in Pharmacology from The University of Manchester, which she completed in 2007. Furthermore, she obtained her PhD in Molecular Medicine from The University of Manchester, where she specialized in immune cell interactions within the tumor microenvironment.
Research Interests
Maryam Jangani has a scientific interest in the inflammatory milieu of the tumor microenvironment. Her research utilizes molecular, immunological, and genomic screening studies to enhance the understanding of immune cell functions. This focus aims to contribute to the development of targeted therapies in oncology.